Strategic Partnerships Recent partnership with Bioz presents a channel to expand product visibility and access a broader customer base in life sciences; leverage this relationship to cross-sell reagents, proteins, antibodies, and ELISA kits.

Leadership Change New CEO Donna Schelby named in 2023 offers an opportunity to align sales messaging with fresh strategic priorities, potentially accelerating market outreach and partnerships in research reagent distribution.

Facility Expansion Recent construction of a state-of-the-art facility signals capacity to scale product lines and fulfill growing demand; position for larger order commitments, custom kits, and faster fulfillment for established channels.

M&A Activity Past acquisitions and collaborations (Mol Innov, Assured Flow Solutions) indicate openness to integration and joint development; pursue co-development opportunities for ELISA kits and high-demand assay components.

Market Positioning Smaller biotech supplier with revenue under one million and a focused product suite offers a foothold for value pricing, bundled reagent packages, and tech-enabled ordering to win mid-market lab accounts seeking affordable quality.